| Literature DB >> 30180947 |
Ji-Sook Yun1, Je-Hyun Yoon2, Young Jun Choi1, Young Jin Son3, Sunghwan Kim3, Liang Tong4, Jeong Ho Chang5.
Abstract
The decapping exoribonuclease DXO functions in pre-mRNA capping quality control, and shows multiple biochemical activities such as decapping, deNADding, pyrophosphohydrolase, and 5'-3' exoribonuclease activities. Previous studies revealed the molecular mechanisms of DXO based on the structures in complexes with a product, substrate mimic, cap analogue, and 3'-NADP+. Despite several reports on the substrate-specific reaction mechanism, the inhibitory mechanism of DXO remains elusive. Here, we demonstrate that adenosine 3', 5'-bisphosphate (pAp), a known inhibitor of the 5'-3' exoribonuclease Xrn1, inhibits the nuclease activity of DXO based on the results of structural and biochemical experiments. We determined the crystal structure of the DXO-pAp-Mg2+ complex at 1.8 Å resolution. In comparison with the DXO-RNA product complex, the position of pAp is well superimposed with the first nucleotide of the product RNA in the vicinity of two magnesium ions. Furthermore, biochemical assays showed that the inhibition by pAp is comparable between Xrn1 and DXO. Collectively, these structural and biochemical studies reveal that pAp inhibits the activities of DXO by occupying the active site to act as a competitive inhibitor.Entities:
Keywords: 5′-3′ exoribonuclease; Adenosine 3′,5′-bisphosphate; Crystal; DXO; Nuclease inhibitor
Mesh:
Substances:
Year: 2018 PMID: 30180947 PMCID: PMC6145842 DOI: 10.1016/j.bbrc.2018.08.135
Source DB: PubMed Journal: Biochem Biophys Res Commun ISSN: 0006-291X Impact factor: 3.575